Stocks · News reference

Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M Estimate

Aug 11, 2026, 11:03 AMBenzinga Newsdesk

Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 250 percent decrease over earnings of $0.02 per share from

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

XTNT

Source: benzinga
Observed: Aug 11, 2026, 11:03 AM
Checked: Aug 11, 2026, 11:03 AM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 27, 2026, 12:10 PMBenzinga Newsdesk
Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private Brand
The agreement establishes BioHorizons as the exclusive distributor of Xtant's allogeneic growth factor technology into the dental and oral-maxillofacial procedure markets in the United States and Canada, expanding
Read original at benzinga
XTNT
BenzingaAug 11, 2026, 5:06 PMBenzinga Insights
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Neuronetics (NASDAQ:STIM) shares moved upwards by 34.1% to $2.91 during Tuesday's regular session. The market value of their outstanding shares is at $151.0 million. As per the press release, Q2 earnings
Read original at benzinga
ACB AIXC ALMR CRIS GRI
BenzingaAug 11, 2026, 1:11 PMBenzinga Newsdesk
Xtant Medical Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its fY26 sales guidance.
Read original at benzinga
XTNT
SEC EDGARAug 11, 2026, 11:05 AMSEC EDGAR
8-K filing — Xtant Medical Holdings, Inc. (XTNT)
Filed: 2026-08-11 AccNo: 0001493152-26-036979 Size: 381 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar
XTNT

Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M Estimate

Connected markets

Related headlines

Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private Brand

12 Health Care Stocks Moving In Tuesday's Intraday Session

Xtant Medical Holdings shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its fY26 sales guidance.

8-K filing — Xtant Medical Holdings, Inc. (XTNT)